Statin Use with Warfarin: Key Precautions
Magnitude of Interaction
- Atorvastatin, rosuvastatin, and simvastatin increase mean INR by approximately 0.3, with peak elevation occurring around 4 weeks after initiation 1, 2, 3, 4, 5, 6
- The American Heart Association recommends atorvastatin due to its minimal INR impact 1, 2, 3, 4, 5, 6
Statin Selection Strategy
- Pitavastatin (4 mg dose) does not appreciably increase INR levels 1, 2, 3, 4, 5, 6
- Atorvastatin has minimal INR impact according to American Heart Association recommendations 1, 2, 3, 4, 5, 6
Monitoring Protocol
- Check INR within 1 week of statin initiation 1, 2, 3, 4, 5, 6
- Repeat INR at 4 weeks (peak interaction period) 1
Mechanism of Interaction
- Protein displacement: Statins displace warfarin from plasma protein binding sites, increasing unbound (active) warfarin concentration 1, 2, 3, 4, 5, 6
- CYP3A4 inhibition: Atorvastatin, rosuvastatin, and simvastatin inhibit this enzyme, reducing warfarin metabolism 1, 2, 3, 4, 5, 6
- CYP2C9 inhibition: Fluvastatin specifically inhibits this pathway, affecting the more potent S-isomer of warfarin 1, 2, 3, 4, 5, 6
Clinical Pitfalls to Avoid
- Assuming all statins are equivalent: Fluvastatin's CYP2C9 inhibition makes it particularly problematic 1, 2, 3, 4, 5, 6